was successfully added to your cart.

Your SEO optimized title page contents
Australian Cannabis Consulting

Image Source

The marijuana industry as a whole has yet another reason to celebrate, as the Australian Parliament and Senate lawmakers have approved amendments to the Narcotic Drugs Act of 1967. The new legislation will oversee the licensing of manufacturing and distribution of marijuana, which can now legally be grown for medicinal and scientific purposes. There will be two different categories of medical cannabis licenses accessible under the new bill. The first enables cannabis to be farmed and manufactured into medicinal cannabis products, and the the second allows for the research of cannabis and its potential medicinal uses.

Lucy Haslam, who drove this campaign and lead the fight with the inception of her organization called United in Compassionlost her son Daniel to terminal bowel cancer exactly one year ago. He was 20 years old. She argued and bravely admitted that, due to the nausea and sickness caused by her son’s chemotherapy treatments, she used cannabis to control the side effects. “[Daniel] would really be at peace today,” Haslam stated after hearing the news. “He didn’t want to die…but it would give him peace to know this is going to help so many Australians. I think he’d be proud.” Australian Sen. Richard Di Natale addressed Parliament on Wednesday and brought up this emotional story. “It is incredibly fitting that today we are passing this bill which is one step towards making medicinal cannabis accessible to people like Dan.” See Sen. Natale’s full speech: http://www.cnn.com/2016/02/24/health/medical-marijuana-legal-australia-irpt/.

Image Source

Australia’s Minister for Health, Sussan Ley, was quoted as saying “This is an historic day for Australia and the many advocates who have fought long and hard to challenge the stigma around medicinal cannabis products so genuine patients are no longer treated as criminals.” Ms. Ley went on to say that “This is the missing piece in a patient’s treatment journey, and [we] will now see seamless access to locally produced medicinal cannabis products from farm to pharmacy.”

As with all new legislation, especially in the marijuana industry, details such as what types can be grown and manufactured have yet to be sorted out. Supporters of the amendment remain hopeful that this will be a relatively quick and painless process and that we may see the first yield being planted within a month or so.

Woody Ellis is a contributing writer for Quantum 9, Inc. You can follow Quantum 9, Inc. on Facebook or Twitter by visiting these addresses:

https://www.facebook.com/quantum9.net/
https://twitter.com/Quantum911

 

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply